Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.
about
Cardiac syndrome X and microvascular coronary dysfunctionWomen and Ischemic Heart Disease: Recognition, Diagnosis and ManagementWomen and Chest Pain: Recognizing the Different Faces of Angina in the Emergency DepartmentStrategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientistsA randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserveCoronary microvascular dysfunction in the clinical setting: from mystery to realityCoronary microvascular dysfunction, microvascular angina, and treatment strategies.Coronary microvascular dysfunction in women: an overview of diagnostic strategiesCurrent developments and future applications of intracoronary hemodynamicsSex differences in cardiovascular disease - Impact on care and outcomes.Behavioral, emotional and neurobiological determinants of coronary heart disease risk in women.Coronary Microvascular Dysfunction, Microvascular Angina, and Management.Cardiac magnetic resonance imaging for myocardial perfusion and diastolic function-reference control values for women.Cardiovascular Disease in Women: Clinical Perspectives.Comparison of low and high dose intracoronary adenosine and acetylcholine in women undergoing coronary reactivity testing: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)Determinants of coronary flow reserve in non-diabetic patients with chest pain without myocardial perfusion defectsDiastolic dysfunction in women with signs and symptoms of ischemia in the absence of obstructive coronary artery disease: a hypothesis-generating studyCoronary circulation; macro or micro, that it the question.Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation.Gender differences in the prevalence of coronary artery tortuosity and its association with coronary artery disease.Effects of sex on coronary microvascular dysfunction and cardiac outcomes.Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease.The Challenges of Prevention, Diagnosis and Treatment of Ischemic Heart Disease in WomenSafety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.Evolving strategies for the treatment of microvascular angina in women.The anti-ischemic and anti-anginal properties of statinsAn intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).Coronary microvascular dysfunction: an updateIschaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of CardiologyRole of echocardiography in the management of cardiac disease in women.Brachial artery constriction during brachial artery reactivity testing predicts major adverse clinical outcomes in women with suspected myocardial ischemia: results from the NHLBI-sponsored women's ischemia Syndrome Evaluation (WISE) Study.Etiopathogenesis of microvascular angina: caveats in our knowledge.Number and function of bone-marrow derived angiogenic cells and coronary flow reserve in women without obstructive coronary artery disease: a substudy of the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)Current Diagnostic and Therapeutic Strategies in Microvascular Angina.Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and managementMicrovascular coronary dysfunction and ischemic heart disease: where are we in 2014?Burden of hospital admission and repeat angiography in angina pectoris patients with and without coronary artery disease: a registry-based cohort study.Mild renal dysfunction and long-term adverse outcomes in women with chest pain: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)The relationship between endothelial progenitor cell populations and epicardial and microvascular coronary disease-a cellular, angiographic and physiologic study.
P2860
Q24618107-3D8218FE-E0C9-467A-B5FC-821436FEB616Q26740081-C96E2707-0044-45DC-BDA6-B28A4E598860Q26746172-4FB10411-C363-4FC3-83A9-9409E1A685FEQ26749044-9CC79DC4-6F8C-481C-8F9A-9D1D714C6CE6Q26776330-7450FD12-D77D-4E11-8B9C-F5B9074E4EBEQ26849534-E99EF271-74AA-4661-80FC-CAB8C3F9C751Q26861073-96CC3515-6BAE-4DB2-9B81-7BAEF68E7DCDQ27024500-58865732-9045-44CA-86FF-08887430F904Q28083138-05FBF1D4-A0A3-4FF3-BC7F-5DFBD9BAEF69Q30234726-7EC439F9-439F-4F93-823F-4F5753EEB2CFQ30248607-53708BEF-8042-4419-86F0-6D559CBBF18FQ30277875-1CD35B8A-5260-4FAD-922A-82AA4C50C05DQ30390910-DC4D803D-C626-4521-9691-6FB6B00621CAQ30743765-BB87D8A8-0E3E-480A-99A5-F74B3A6840D7Q33554288-9FBA06A3-645C-4221-A929-E9BF59B75E7BQ33572992-C0A05633-0DA0-4741-B5D3-A48726C0C52FQ33610922-FC52891D-72F4-4388-A6DC-D1D78F787CADQ33650828-266473E7-716B-4DC9-A338-A46E1C466598Q33681933-017CDA73-657A-4830-8BAB-34438084B541Q33725441-B0A5E109-6B93-4A14-A15E-311F65E0918FQ33753554-85933D63-E9B7-40B9-8FEE-B85C0D773BE8Q33825527-D1ADA8C6-E9E5-42A7-8A62-60FC196B01F4Q33841979-023A227D-37D9-4346-85F7-9555A9EB9342Q33917513-03FA534F-225E-40D6-A91E-4EA9B3CEFD6BQ34313090-B1808734-8271-46A1-A3EE-D0D89319089FQ34317991-C381AFC4-D893-41D7-BC8E-F19A73970793Q34477330-D9CC9AB9-1D1D-449C-B3E2-C3B0AE7615CAQ34481332-E6BFD579-6195-4AC5-BBE0-93FA5CDB1748Q34658569-11DE99C2-B41E-416C-909E-107AB0B77664Q34682870-384D785F-A37C-451E-B688-C378018D12A8Q34863501-19831A1F-DAF0-493D-8B72-92D590837208Q34994772-39EF523F-8F8F-4CDA-A3F7-FD6BA103C621Q35028667-03754F21-0261-477D-9625-703C84C5CED6Q35061266-FDA77D52-0073-4CE6-8F54-4B34FF41BC30Q35077560-EF985924-D189-4264-AC2F-8E71D0D1C7F3Q35093085-B5F137AA-0A0E-46E7-9BBB-4DFDAF432C8BQ35108848-28768248-83CC-4424-9DB7-0EB50AE58459Q35140200-11632F94-5109-4414-9A36-7ED7D47DCF37Q35141989-ED43C124-5282-4972-A783-4B9ED031F979Q35148886-02EC309D-1089-424F-AFC5-554A6DE8251E
P2860
Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Coronary microvascular reactiv ...... ia Syndrome Evaluation) study.
@ast
Coronary microvascular reactiv ...... ia Syndrome Evaluation) study.
@en
type
label
Coronary microvascular reactiv ...... ia Syndrome Evaluation) study.
@ast
Coronary microvascular reactiv ...... ia Syndrome Evaluation) study.
@en
prefLabel
Coronary microvascular reactiv ...... ia Syndrome Evaluation) study.
@ast
Coronary microvascular reactiv ...... ia Syndrome Evaluation) study.
@en
P2093
P2860
P1476
Coronary microvascular reactiv ...... mia Syndrome Evaluation) study
@en
P2093
B Delia Johnson
Barry L Sharaf
Carl J Pepine
Eileen M Handberg
George Sopko
Karen M Smith
R David Anderson
P2860
P304
P356
10.1016/J.JACC.2010.01.054
P407
P577
2010-06-01T00:00:00Z